Study details
Enrolling now
HARP Pilot 2 Trial
Yale University
NCT IDNCT06513819ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
100
Study length
about 12 months
Ages
50+
Locations
1 site in CT
What this study is about
This trial is testing a new approach called IMB-MI to help people with HIV manage their alcohol, cannabis use, and medications. The goal is to reduce falls and improve thinking skills by addressing these factors together.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Information Motivation Behavioral and Motivational Interviewing (IMB-MI) technique
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Neurocognitive symptoms mean score
Body systems
Immune, Infectious